한독

002390KOSPI의약품 제조업

54.6 / 100

Reference Date: 2026-07-24

Financial Score13.5 / 40

News Sentiment19.1 / 25

Momentum12.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Surged 21.5% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Han Dong, established in 1954, operates in pharmaceuticals, medical devices, health functional foods, and real estate leasing. Key products include Amaryl, Tenelria, and RediQ, with headquarters in Seoul's Gangnam-gu, a factory in Yongcheon, Chungcheongbuk, and a research institute in Gangseo-gu, Seoul. The company operates across multiple business segments.

Number of Employees

951people

Average Salary

78.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 11.234.0Point

PBR

0.42Industry Average 0.815.5Point

Lower than industry avg (good)

ROE

-0.79Industry Average 4.010.0Point

Well below industry avg

Debt Ratio

34.98Industry Average 12.430.0Point

2.8x industry avg (risky)

Trend 2023~20254.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲1.3% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲207.8% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -8.5% (improving, 3yr)

Detailed News Sentiment

14 totalPositive 11Neutral 3Negative 0Average Sentiment Score 76.4

Positive
한독·웰트 “'슬립큐' 대면 불면증 치료와 유사 효과 가능성 확인”
한독과 웰트의 슬립큐 디지털치료기기가 대면 CBT-I와 유사한 효과와 높은 환자 순응도를 보여 긍정적인 시장 반응을 기대.
Positive
한독·웰트 "슬립큐, 대면 CBT-I와 유사한 치료효과"
한독과 웰트의 슬립큐 디지털 치료기기가 임상 연구를 통해 대면 CBT-I와 유사한 효과와 높은 환자 순응도를 보여 긍정적인 시장 반응 예상.
Positive
한독·웰트 디지털 불면증 치료기기 '슬립큐', 대면 치료와 유사한 효...
한독의 슬립큐 디지털 불면증 치료기기가 대면 치료와 유사한 효과를 보여주며 환자 순응도 향상에 기여할 것으로 기대됩니다.

Detailed Momentum

52-week position3.0Point

52w lower range (33%)

Current 8,580Won52-week high 12,36052-week low 6,700

1-month return6.0Point

1m +21.53% (strong rise)

Volume trend3.0Point

Volume flat

Detailed Disclosure

7 totalPositive 0Neutral 7Negative 0

Neutral최대주주등소유주식변동신고서2026-07-20
Neutral주식등의대량보유상황보고서(일반)2026-07-20
Neutral주식등의대량보유상황보고서(일반)2026-07-20
Neutral최대주주등소유주식변동신고서2026-07-20
Neutral공정거래자율준수프로그램운영현황(안내공시)2026-07-15